Publications

  1. Muchtar E, Lin G, Grogan M. The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis. Can J Cardiol. 2020 Mar; 36 (3):384-395 Epub 2019 Dec 09
    View PubMed
  2. Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 Feb 15 [Epub ahead of print]
    View PubMed
  3. Pinto MV, Milone M, Mauermann ML, Dyck PJB, Alhammad R, McPhail ED, Grogan M, Liewluck T. Transthyretin amyloidosis: Putting myopathy on the map. Muscle Nerve. 2020 Jan; 61 (1):95-100 Epub 2019 Oct 21
    View PubMed
  4. Muchtar E, Gertz MA, Lacy MQ, Go RS, Buadi FK, Dingli D, Grogan M, AbouEzzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Dispenzieri A. Ten-year survivors in AL amyloidosis: characteristics and treatment pattern. Br J Haematol. 2019 Dec; 187 (5):588-594 Epub 2019 July 12
    View PubMed
  5. Fayyaz AU, Bois MC, Dasari S, Padmanabhan D, Vrana JA, Stulak JM, Edwards WD, Kurtin PJ, Asirvatham SJ, Grogan M, Maleszewski JJ. Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications. Mod Pathol. 2019 Nov 13 [Epub ahead of print]
    View PubMed
  6. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019 Sep; 12 (9):e006075 Epub 2019 Sept 04
    View PubMed
  7. Gertz MA, Mauermann ML, Grogan M, Coelho T. Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain Behav. 2019 Sep; 9 (9):e01371 Epub 2019 Aug 01
    View PubMed
  8. Pislaru C, Ionescu F, Alashry M, Petrescu I, Pellikka PA, Grogan M, Dispenzieri A, Pislaru SV. Myocardial Stiffness by Intrinsic Cardiac Elastography in Patients with Amyloidosis: Comparison with Chamber Stiffness and Global Longitudinal Strain. J Am Soc Echocardiogr. 2019 Aug; 32 (8):958-968.e4 Epub 2019 June 21
    View PubMed
  9. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. J Am Coll Cardiol. 2019 Jul 23; 74 (3):285-295 Epub 2019 Mar 15
    View PubMed
  10. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Jun 11; 73 (22):2872-2891
    View PubMed
  11. Sidiqi MH, Dasari S, McPhail ED, Buadi FK, Warsame R, Lacy MQ, Dingli D, Gonsalves WI, Kapoor P, Kourelis T, Leung N, Muchtar E, Grogan M, Lust JA, Kumar S, Kyle RA, Rajkumar VS, Gertz M, Dispenzieri A. Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis. Am J Hematol 2019 May; 94 (5):E141-E143 Epub 2019 Feb 27
    View PubMed
  12. Pinto MV, Tracy JA, Grogan M, Mauermann ML. Teaching NeuroImages: Neuromyopathy in a patient with hereditary transthyretin Thr60Ala amyloidosis. Neurology. 2019 Mar 19; 92 (12):e1403-e1404
    View PubMed
  13. Sidiqi MH, McPhail ED, Theis JD, Dasari S, Vrana JA, Drosou ME, Leung N, Hayman S, Rajkumar SV, Warsame R, Ansell SM, Gertz MA, Grogan M, Dispenzieri A. Two types of amyloidosis presenting in a single patient: a case series. Blood Cancer J. 2019 Mar 5; 9 (3):30 Epub 2019 Mar 05
    View PubMed
  14. Chang IC, Dispenzieri A, Scott CG, Lin G, Jaffe AS, Klarich KW, Grogan M. Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure. Mayo Clin Proc. 2019 Mar; 94 (3):447-454 Epub 2019 Feb 02
    View PubMed
  15. Sidana S, Tandon N, Brady PA, Grogan M, Gertz MA, Dispenzieri A, Lin G, Dingli D, Buadi FK, Lacy MQ, Kapoor P, Gonsalves WI, Muchtar E, Warsame R, Kumar SK, Kourelis TV. Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis. Mayo Clin Proc. 2019 Mar; 94 (3):455-464 Epub 2019 Feb 02
    View PubMed
  16. El-Am EA, Dispenzieri A, Melduni RM, Ammash NM, White RD, Hodge DO, Noseworthy PA, Lin G, Pislaru SV, Egbe AC, Grogan M, Nkomo VT. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis. J Am Coll Cardiol. 2019 Feb 12; 73 (5):589-597
    View PubMed
  17. Solomon SD, Adams D, Kristen A, Grogan M, Gonzalez-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 2019 Jan 22; 139 (4):431-443
    View PubMed
  18. Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW. Contemporary Imaging Diagnosis of Cardiac Amyloidosis. J Cardiovasc Imaging. 2019 Jan; 27 (1):1-10
    View PubMed
  19. Chang IC, Scott CG, Dispenzieri A, AbouEzzeddine O, Lin G, Grogan M. Transthyretin amyloidosis in patients with undifferentiated heart failure. Amyloid. 2019; 26 (sup1):33-34
    View PubMed
  20. Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA. Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria. Amyloid. 2019; 26 (sup1):101-102
    View PubMed
  21. Rosenbaum AN, AbouEzzeddine OF, Grogan M, Dispenzieri A, Kushwaha S, Clavell A, Daly RC, Edwards BS. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis. Transplantation. 2018 Nov; 102 (11):1909-1913
    View PubMed
  22. Mankad , R., Grogan , M.. Diagnosis of Cardiac Amyloidosis: Clinical and echocardiographic Features Current Cardiovascular Imaging Reports. 2018; 11(32).
  23. Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA. Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria. Leukemia. 2018 Oct; 32 (10):2240-2249 Epub 2018 Feb 20
    View PubMed
  24. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13; 379 (11):1007-1016 Epub 2018 Aug 27
    View PubMed
  25. Java AP, Greason KL, Dispenzieri A, Grogan M, King KS, Maleszewski JJ, Daly RC, Eleid MF, Pochettino A, Schaff HV. Aortic valve replacement in patients with amyloidosis. J Thorac Cardiovasc Surg. 2018 Jul; 156 (1):98-103 Epub 2017 Dec 19
    View PubMed
  26. Illman JE, Arunachalam SP, Arani A, Chang IC, Glockner JF, Dispenzieri A, Grogan M, Araoz PA. MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis. Amyloid. 2018 Jun; 25 (2):101-108 Epub 2018 May 07
    View PubMed
  27. Muchtar E, Gertz MA, Kumar SK, Lin G, Boilson B, Clavell A, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Dingli D, Rajkumar SV, Dispenzieri A, Grogan M. Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use? Amyloid. 2018 Jun; 25 (2):86-92 Epub 2018 Mar 12
    View PubMed
  28. Milani P, Dispenzieri A, Scott CG, Gertz MA, Perlini S, Mussinelli R, Lacy MQ, Buadi FK, Kumar S, Maurer MS, Merlini G, Hayman SR, Leung N, Dingli D, Klarich KW, Lust JA, Lin Y, Kapoor P, Go RS, Pellikka PA, Hwa YL, Zeldenrust SR, Kyle RA, Rajkumar SV, Grogan M. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis. Circ Cardiovasc Imaging. 2018 May; 11 (5):e006588
    View PubMed
  29. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1130-1148
    View PubMed
  30. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1149-1166
    View PubMed
  31. Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive (99m)Technetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2018 Jan; 11 (1)
    View PubMed
  32. Arani A, Arunachalam SP, Chang ICY, Baffour F, Rossman PJ, Glaser KJ, Trzasko JD, McGee KP, Manduca A, Grogan M, Dispenzieri A, Ehman RL, Araoz PA. Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis. J Magn Reson Imaging. 2017 Nov; 46 (5):1361-1367 Epub 2017 Feb 25
    View PubMed
  33. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. JAMA Oncol. 2017 Sep 1; 3 (9):1257-1265
    View PubMed
  34. Banerjee D, Roeker LE, Grogan M, Swiecicki P, Poterucha J, Heimbach J, Zeldenrust S, Gertz M, Edwards B, Daly R, Klarich KW, Dispenzieri A. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation. Prog Transplant. 2017 Sep; 27 (3):246-250 Epub 2017 July 04
    View PubMed
  35. Muchtar E, Grogan M, Dasari S, Kurtin PJ, Gertz MA. Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation. J Neurol Sci. 2017 Aug 15; 379:192-197 Epub 2017 June 13
    View PubMed
  36. Grogan M, Dispenzieri A, Gertz MA. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart. 2017 Jul; 103 (14):1065-1072 Epub 2017 Apr 29
    View PubMed
  37. Bois MC, Dasari S, Mills JR, Theis J, Highsmith WE, Vrana JA, Grogan M, Dispenzieri A, Kurtin PJ, Maleszewski JJ. Apolipoprotein A-IV-Associated Cardiac Amyloidosis. J Am Coll Cardiol 2017 May 2; 69 (17):2248-2249
    View PubMed
  38. Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, Grogan M, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Dispenzieri A. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death. Blood. 2017 Apr 13; 129 (15):2111-2119 Epub 2017 Jan 26
    View PubMed
  39. Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, Pellikka PA, Villarraga HR. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. JACC Cardiovasc Imaging. 2017 Apr; 10 (4):398-407 Epub 2016 Sept 14
    View PubMed
  40. Sperry BW, Dispenzieri A, Ikram A, Grogan M, Theis JD, Leung N, Highsmith WE, Maleszewski JJ, Hanna M. Complex p.T88N/W130R mutation in the lysozyme gene leading to hereditary lysozyme amyloidosis with biopsy-proven cardiac involvement. Amyloid 2017 Mar; 24 (1):60-61 Epub 2017 Mar 22
    View PubMed
  41. Chang ICY, Arani A, Poigai Arunachalam S, Grogan M, Dispenzieri A, Araoz PA. Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis. Amyloid. 2017 Mar; 24 (sup1):161
    View PubMed
  42. Maurer M, Lousada I, Hanna M, Ruberg F, Mohty D, Dispenzieri A, Liedtke M, Paulson I, Vest J, Grogan M. Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016. Amyloid. 2017 Mar; 24 (sup1):165-166
    View PubMed
  43. El Sabbagh A, Al-Hijji MA, Thaden JJ, Pislaru SV, Pislaru C, Pellikka PA, Arruda-Olson AM, Grogan M, Greason KL, Maleszewski JJ, Klarich KW, Nkomo VT. Cardiac Myxoma: The Great Mimicker. JACC Cardiovasc Imaging. 2017 Feb; 10 (2):203-206
    View PubMed
  44. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 1; 1 (8):880-889
    View PubMed
  45. Tan NY, Mohsin Y, Hodge DO, Lacy MQ, Packer DL, Dispenzieri A, Grogan M, Asirvatham SJ, Madhavan M, McLEOD CJ. Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis. J Cardiovasc Electrophysiol. 2016 Oct; 27 (10):1167-1173 Epub 2016 Aug 26
    View PubMed
  46. Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL. Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia. 2016 Oct; 30 (10):1979-1986 Epub 2016 July 15
    View PubMed
  47. Saiki H, Eidem BW, Ohtani T, Grogan MA, Redfield MM. Ventricular-Arterial Function and Coupling in the Adult Fontan Circulation. J Am Heart Assoc. 2016 Sep 23; 5 (9) Epub 2016 Sept 23
    View PubMed
  48. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, Klarich KW, Miller WL, Maleszewski JJ, Dispenzieri A. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. J Am Coll Cardiol. 2016 Sep 6; 68 (10):1014-20
    View PubMed
  49. Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Plante-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, THAOS Investigators. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol. 2016 Jul 12; 68 (2):161-72
    View PubMed
  50. Liang JJ, Grogan M, Ackerman MJ. LMNA-Mediated Arrhythmogenic Right Ventricular Cardiomyopathy and Charcot-Marie-Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis. J Cardiovasc Electrophysiol. 2016 Jul; 27: (7)868-71.
    View PubMed
  51. Grogan M, Gertz M, McCurdy A, Roeker L, Kyle R, Kushwaha S, Daly R, Dearani J, Rodeheffer R, Frantz R, Lacy M, Hayman S, McGregor C, Edwards B, Dispenzieri A. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience. World J Transplant. 2016 Jun 24; 6 (2):380-8
    View PubMed
  52. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133 (24):2404-12 Epub 2016 Apr 22
    View PubMed
  53. Ong KC, Askew JW, Dispenzieri A, Maleszewski JJ, Klarich KW, Anavekar NS, Mulvagh SL, Grogan M. Abnormal stress echocardiography findings in cardiac amyloidosis. Amyloid. 2016 Jun; 23: (2)124-31.
    View PubMed
  54. Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, Araoz PA. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016 Jun; 9 (6):680-6 Epub 2016 May 18
    View PubMed
  55. Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, Phillips SD, Connolly HM, Ammash NM, Warnes CA, Friedman PA. Right Parasternal Lead Placement Increases Eligibility for Subcutaneous Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease. Circ J. 2016 May 25; 80 (6):1328-35 Epub 2016 Apr 22
    View PubMed
  56. Larsen BT, Mereuta OM, Dasari S, Fayyaz AU, Theis JD, Vrana JA, Grogan M, Dogan A, Dispenzieri A, Edwards WD, Kurtin PJ, Maleszewski JJ. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. Histopathology. 2016 Apr; 68 (5):648-56 Epub 2015 Sept 28
    View PubMed
  57. Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. J Am Coll Cardiol. 2015 Dec 01; 66 (21):2451-2466
    View PubMed
  58. Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, Grogan M, Kapoor P, Lust JA, Dingli D, Go RS, Hwa YL, Hayman SR, Fonseca R, Ailawadhi S, Bergsagel PL, Chanan-Khan A, Rajkumar SV, Russell SJ, Stewart K, Zeldenrust SR, Gertz MA. Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement. Mayo Clin Proc. 2015 Aug; 90(8):1054-81.
    View PubMed
  59. Swiecicki PL, Zhen DB, Mauermann ML, Kyle RA, Zeldenrust SR, Grogan M, Dispenzieri A, Gertz MA. Hereditary attr amyloidosis: a single-institution experience with 266 patients. Amyloid. 2015 Jun; 22(2):123-31.
    View PubMed
  60. Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. Am J Hematol. 2015 Jun; 90: (6)524-8.
    View PubMed
  61. Grogan M, Dispenzieri A. Natural history and therapy of AL cardiac amyloidosis. Heart Fail Rev. 2015 Mar; 20 (2):155-62
    View PubMed
  62. Leung N, Grogan M, Johnson GB, Klecka ME, Dispenzeiri A. Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum? Am J Hematol. 2015; 90(5):462-5.
    View PubMed
  63. Sabate Rotes A, Burkhart HM, Suri RM, Grogan M, Taggart NW, Li Z, Schaff HV, Dearani JA. Minimally invasive video-assisted surgical closure of atrial septal defects: a safe approach. World J Pediatr Congenit Heart Surg. 2014 Oct; 5(4):527-33.
    View PubMed
  64. Raju V, Dearani JA, Burkhart HM, Grogan M, Phillips SD, Ammash N, Pike RP, Johnson JN, O'Leary PW. Right ventricular unloading for heart failure related to Ebstein malformation. Ann Thorac Surg. 2014 Jul; 98(1):167-73; discussion 173-4. Epub 2014 May 6
    View PubMed
  65. Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014 May 15; 113 (10):1723-7 Epub 2014 Mar 02
    View PubMed
  66. Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr. 2014 Apr; 27 (4):440-7 Epub 2014 Jan 18
    View PubMed
  67. Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, Grogan M, Zeldenrust SR, Hayman SR, Buadi F, Greipp PR, Leung N, Russell SR, Dingli D, Lust JA, Rajkumar SV, Jaffe AS. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014 Mar; 100 (5):383-8 Epub 2014 Jan 08
    View PubMed
  68. Arruda-Olson AM, Zeldenrust SR, Dispenzieri A, Gertz MA, Miller FA, Bielinski SJ, Klarich KW, Scott CG, Grogan M. Genotype, echocardiography, and survival in familial transthyretin amyloidosis. Amyloid. 2013 Dec; 20(4):263-8. Epub 2013 Oct 16.
    View PubMed
  69. Brenes-Salazar JA, Grogan M, Lacy MQ. A 66-year-old woman with an enlarged tongue. Cleve Clin J Med. 2013 Nov; 80(11):696-7.
    View PubMed
  70. Lin G, Dispenzieri A, Kyle R, Grogan M, Brady PA. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. J Cardiovasc Electrophysiol. 2013 Jul; 24(7):793-8. Epub 2013 Mar 14.
    View PubMed
  71. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013 May-Jun; 22(3):189-94. Epub 2012 Oct 24.
    View PubMed
  72. Hussain FT, Grogan M, Dearani JA. Surgical repair of tetralogy of fallot at age 83. World J Pediatr Congenit Heart Surg. 2012 Oct 1; 3(4):518-20.
    View PubMed
  73. Bellavia D, Pellikka PA, Dispenzieri A, Scott CG, Al-Zahrani GB, Grogan M, Pitrolo F, Oh JK, Miller FA Jr. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging. 2012 Aug; 13 (8):680-9 Epub 2012 Feb 03
    View PubMed
  74. Bonnichsen CR, Glockner JF, Grogan M. Improvement in myocardial delayed enhancement after autologous stem cell transplant in a patient with light chain amyloidosis. Circ Heart Fail. 2012 May 1; 5(3):e55.
    View PubMed
  75. Madan S, Kumar SK, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Rajkumar SV, Hogan WJ, Leung N, Grogan M, Gertz MA. High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement. Blood. 2012 Feb 2; 119 (5):1117-22 Epub 2011 Dec 06
    View PubMed
  76. Lee GK, Klarich KW, Grogan M, Cha YM. Premature ventricular contraction-induced cardiomyopathy: a treatable condition. Circ Arrhythm Electrophysiol. 2012 Feb; 5(1):229-36.
    View PubMed
  77. Shah DK, Joyce LD, Grogan M, Aubry MC, Miller JA, Ding W, Haddock MG. Recurrent pulmonary intimal sarcoma involving the right ventricular outflow tract. Ann Thorac Surg. 2011 Mar; 91: (3)e41-2.
    View PubMed
  78. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, Gertz MA, Dispenzieri A, Oh JK, Bellavia D, Tajik AJ, Grogan M. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010 Feb; 3: (2)155-64.
    View PubMed
  79. Fealey ME, Edwards WD, Buadi FK, Syed IS, Grogan M. Echocardiographic features of cardiac amyloidosis presenting as endomyocardial disease in a 54-year-old male. J Cardiol. 2009 Aug; 54: (1)162-6.
    View PubMed
  80. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, Edwards WD, Gertz MA, Klarich KW. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009 May 12; 119(18):2490-7. Epub 2009 May 04.
    View PubMed
  81. Rehfeldt KH, Mauermann WJ, Suri RM, Grogan M. The diagnosis of Shone's anomaly by intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2009 Feb; 23: (1)75-6.
    View PubMed
  82. Fealey ME, Edwards WD, Grogan M, Orszulak TA. Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):44-8. Epub 2007 Nov 19.
    View PubMed
  83. Silvilairat S, Cabalka AK, Cetta F, Grogan M, Hagler DJ, O'Leary PW. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis. 2008 Jul-Aug; 3(4):262-8.
    View PubMed
  84. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed II, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007 Nov 20; 116(21):2420-6.
    View PubMed
  85. Fealey ME, Edwards WD, Grogan M, Dispenzieri A. Primary cardiac amyloidosis with 20-year survival. Cardiovasc Pathol. 2006 Nov-Dec; 15(6):331-5.
    View PubMed
  86. Earing MG, Connolly HM, Dearani JA, Ammash NM, Grogan M, Warnes CA. Long-term follow-up of patients after surgical treatment for isolated pulmonary valve stenosis. Mayo Clin Proc. 2005 Jul; 80: (7)871-6.
    View PubMed
  87. Qaddoura F, Connolly H, Grogan M, Orszulak TA, Schaff HV, Chandrasekaran K, Click RL. Valve morphology in antiphospholipid antibody syndrome: echocardiographic features. Echocardiography. 2005 Mar; 22(3):255-9.
    View PubMed
  88. Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Grogan M, Jalal SM, Michels VV. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005 Feb 15; 45(4):595-8.
    View PubMed
  89. Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005 Feb 15; 95(4):535-7.
    View PubMed
  90. Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol. 2004 Jul 7; 44(1):174-80.
    View PubMed
  91. Grogan M, Warnes CA. The adult with successful childhood repair of ASD/coarctation/or VSD: what should I watch for? ACC Current Journal Review. 2003 Jan-Feb; 12(1):97-100.
  92. Teramae CY, Connolly HM, Grogan M, Miller FA Jr. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience. Mayo Clin Proc. 2000 May; 75: (5)456-61.
    View PubMed
  93. Grogan M, Gertz MA, Kyle RA, Tajik AJ. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2000 Mar 1; 85 (5):664-5, A11
    View PubMed
  94. Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine. Mayo Clin Proc. 1999 Dec; 74: (12)1191-7.
    View PubMed
  95. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol. 1999 May; 33 (6):1692-5
    View PubMed
  96. Grogan M, Klarich KW. Coronary artery disease in Women: Evaluation and Prevention. Your Patient & Fitness. 1998 Jul/Aug; 12(4):6-10.
  97. Sutton-Tyrrell K, Rihal C, Sellers MA, Rihal C, Burek K, Trudel J, Roubin G, Brooks MM, Grogan M, Sopko G, Keller N, Jandova R. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998 Feb 15; 81 (4):375-81
    View PubMed
  98. Grogan M, Klarich KW, Smith HC. Heart disease in women. Your Patient and Fitness. 1998; 12(4):6-10.
  99. Gertz MA, Grogan M, Kyle RA, Tajik AJ. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy. Am J Cardiol. 1997 Jul 1; 80 (1):93-5
    View PubMed
  100. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1995 Jul; 26 (1):80-4
    View PubMed
  101. Lloyd MA, Grogan M, Sandberg SM, Smith HC, Gersh BJ, Edwards WD, Edwards BS. Presence of atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy. Am J Cardiol. 1994 May 15; 73 (13):984-6
    View PubMed
  102. Grogan M, Christian TF, Miller TD, Bailey KR, Gibbons RJ. The effect of systemic hypertension on exercise tomographic thallium-201 imaging in the absence of electrocardiographic left ventricular hypertrophy. Am Heart J. 1993 Aug; 126 (2):327-32
    View PubMed
  103. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Jun 15; 69 (19):1570-3
    View PubMed